Safety and efficacy of MitraClip in acutely ill (NYHA Class IV) patients with mitral regurgitation: Results from the global EXPAND study
Sign Up to like & getrecommendations! Published in 2023 at "ESC Heart Failure"
DOI: 10.1002/ehf2.14273
Abstract: Patients with severe mitral regurgitation (MR) and acute heart failure (HF) have refractory symptoms without adequate response to medical therapy. The objective of this analysis was to assess the impact of the MitraClip device in… read more here.
Keywords: nyha class; mitraclip; acutely ill; mitral regurgitation ... See more keywords
Pregnancy outcomes in women with mitral valve stenosis: 10-year experience of a tertiary care center
Sign Up to like & getrecommendations! Published in 2025 at "Archives of Gynecology and Obstetrics"
DOI: 10.1007/s00404-024-07900-9
Abstract: Mitral stenosis (MS) is recognized as one of the most common cardiovascular diseases during pregnancy and can result in adverse outcomes including maternal and fetal mortality if not diagnosed and treated in a timely manner.… read more here.
Keywords: pregnancy outcomes; class; pregnancy; women mitral ... See more keywords
Bone mineral density in older patients with chronic heart failure is related to NYHA classification: a retrospective study
Sign Up to like & getrecommendations! Published in 2018 at "European Geriatric Medicine"
DOI: 10.1007/s41999-018-0027-5
Abstract: PurposeDiscrepant results on relationship between chronic heart failure (CHF) and bone mineral density (BMD) have been reported and little has investigated the association between bone mass loss and New York Heart Association (NYHA) classification in… read more here.
Keywords: heart; nyha classification; class; bmd ... See more keywords
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials
Sign Up to like & getrecommendations! Published in 2017 at "American Heart Journal"
DOI: 10.1016/j.ahj.2017.06.002
Abstract: Background Primary prevention implantable cardioverter defibrillator (ICD) reduce all‐cause mortality by reducing sudden cardiac death. There are conflicting data regarding whether patients with more advanced heart failure derive ICD benefit owing to the competing risk… read more here.
Keywords: class; mortality; icd; primary prevention ... See more keywords
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
Sign Up to like & getrecommendations! Published in 2020 at "The Lancet"
DOI: 10.1016/s0140-6736(20)31792-x
Abstract: BACKGROUND Cardiac muscle hypercontractility is a key pathophysiological abnormality in hypertrophic cardiomyopathy, and a major determinant of dynamic left ventricular outflow tract (LVOT) obstruction. Available pharmacological options for hypertrophic cardiomyopathy are inadequate or poorly tolerated… read more here.
Keywords: placebo; treatment; obstructive hypertrophic; nyha class ... See more keywords
Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy
Sign Up to like & getrecommendations! Published in 2020 at "European Heart Journal"
DOI: 10.1093/ehjci/ehaa946.2115
Abstract: In the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT), tafamidis was shown to be an effective treatment for patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Further assessment of the efficacy of tafamidis in patients with more… read more here.
Keywords: patients advanced; tafamidis patients; class iii; tafamidis ... See more keywords
Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group
Sign Up to like & getrecommendations! Published in 2018 at "Rheumatology"
DOI: 10.1093/rheumatology/kex182
Abstract: Objectives The multisystem manifestations of SSc can greatly impact patients' quality of life. The aim of this study was to identify factors associated with disability in SSc. Methods SSc patients from the prospective DeSScipher cohort… read more here.
Keywords: disability; shaq; study; desscipher ... See more keywords
Abstract 4140558: Circulating plasma proteins in the Fontan circulation predict mitochondrial oxidative stress
Sign Up to like & getrecommendations! Published in 2024 at "Circulation"
DOI: 10.1161/circ.150.suppl_1.4140558
Abstract: Background: Single ventricle congenital heart disease such as hypoplastic left heart syndrome (HLHS) with a Fontan circulation constitute the largest group of children hospitalized with circulation failure, experiencing an in-hospital mortality rate of 20-50%. We… read more here.
Keywords: nyha class; heart; fontan circulation; circulation ... See more keywords
918-P: Effect of Remogliflozin in Improving NYHA Class Compared with Empagliflozin in Type 2 Diabetes Patients with Heart Failure (Remit HF)
Sign Up to like & getrecommendations! Published in 2024 at "Diabetes"
DOI: 10.2337/db24-918-p
Abstract: Background: In patient of T2DM and HF, reduced ejection fraction (HFrEF) constitutes the majority of HF cases, posing significant risk of mortality. NYHA classification, recommended in global HF guidelines, independently predicts mortality. SGLT2i have shown… read more here.
Keywords: improvement; remogliflozin; class iii; class ... See more keywords
Alteration of the gut microbiota and metabolite phenylacetylglutamine in patients with severe chronic heart failure
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2022.1076806
Abstract: Chronic Heart Failure (CHF) is the end result of nearly all cardiovascular disease and is the leading cause of deaths worldwide. Studies have demonstrated that intestinal flora has a close relationship with the development of… read more here.
Keywords: nyha class; chronic heart; heart failure; heart ... See more keywords
Long-term follow-up study on obstructive hypertrophic cardiomyopathy patients treated with disopyramide: evidences of a notable trend in symptom control within a real-world clinical setting
Sign Up to like & getrecommendations! Published in 2024 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2024.1416600
Abstract: Background In obstructive hypertrophic cardiomyopathy (HOCM), disopyramide is used in patients who remain symptomatic despite β-blockers or verapamil. However, effectiveness of disopyramide therapy has not been clearly established due to inconsistent definition of responders and… read more here.
Keywords: obstructive hypertrophic; patients treated; nyha class; hypertrophic cardiomyopathy ... See more keywords